These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1778109)

  • 21. Contribution of hyperglycemia and renal damage to urinary C-peptide clearance in non-insulin-dependent diabetic patients.
    Aoki Y; Yanagisawa Y; Oguchi H; Furuta S
    Diabetes Res Clin Pract; 1991 Nov; 14(2):85-9. PubMed ID: 1756686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
    Kudolo GB
    J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with improvement of fasting plasma glucose level by mealtime dosing of a rapid-acting insulin analog in type 2 diabetes.
    Takamura T; Sakurai M; Nakamura M; Shimizu A; Ota T; Misu H; Takeshita Y; Tsuchiyama N; Kurita S; Ando H; Kaneko S
    Diabetes Res Clin Pract; 2007 Mar; 75(3):278-84. PubMed ID: 17069922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon-stimulated and postprandial plasma C-peptide values as measures of insulin secretory capacity.
    Koskinen PJ; Viikari JS; Irjala KM
    Diabetes Care; 1988 Apr; 11(4):318-22. PubMed ID: 3042307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-peptide and insulin secretion in diabetes mellitus treated with oral hypoglycaemic agents or diet alone. A 3 years epidemiological cohort study on the Island of Falster, Denmark.
    Nielsen NV; Tronier B
    Diabetes Res; 1987 Mar; 4(3):135-9. PubMed ID: 3301161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of endogenous insulin secretion and mode of therapy with body fat and serum leptin levels in diabetic subjects.
    Nagasaka S; Ishikawa S; Nakamura T; Kawakami A; Rokkaku K; Hayashi H; Kusaka I; Higashiyama M; Saito T
    Metabolism; 1998 Nov; 47(11):1391-6. PubMed ID: 9826219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.
    Owens DR; Luzio SD; Ismail I; Bayer T
    Diabetes Care; 2000 Apr; 23(4):518-23. PubMed ID: 10857945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
    Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
    Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
    J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum C-peptide concentrations and their value in evaluating the usefulness of insulin therapy in elderly diabetics.
    Kyllästinen M; Elfving S
    Gerontology; 1986; 32(6):317-26. PubMed ID: 3556328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma C-peptide levels identify insulin-treated diabetic patients suitable for oral hypoglycaemic therapy.
    Grant PJ; Barlow E; Miles DW
    Diabet Med; 1984 Nov; 1(4):284-6. PubMed ID: 6242818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting Plasma Glucose Indicates Reversibility of the Acute Insulin Response after Short-Term Intensive Insulin Therapy in Patients with Various Duration of Type 2 Diabetes.
    Liu L; Yang S; Liu J; Li H; Liu J; Cao X; Xiao H; Li Y
    J Diabetes Res; 2018; 2018():9423965. PubMed ID: 30581872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus.
    Pecoraro RE; Koepsell TD; Chen MS; Lipsky BA; Belcher DW; Inui TS
    Diabetes Care; 1986; 9(4):370-5. PubMed ID: 3743312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agents.
    Iavicoli M; Cucinotta D; De Mattia G; Lunetta M; Morsiani M; Pontiroli AE; Pozza G
    Diabet Med; 1988 Dec; 5(9):849-55. PubMed ID: 2976646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.